Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUPH.OQ)

AUPH.OQ on NASDAQ Stock Exchange Global Market

6.18USD
6:14pm BST
Change (% chg)

$-0.04 (-0.56%)
Prev Close
$6.22
Open
$6.23
Day's High
$6.23
Day's Low
$6.15
Volume
62,671
Avg. Vol
96,395
52-wk High
$7.84
52-wk Low
$5.07

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 4 0.05 0.10 0.03 0.03
Quarter Ending Dec-19 4 0.05 0.10 0.03 0.03
Year Ending Dec-19 4 0.16 0.30 0.12 0.13
Year Ending Dec-20 3 25.14 75.12 0.11 30.67
Earnings (per share)
Quarter Ending Sep-19 4 -0.18 -0.16 -0.20 -0.24
Quarter Ending Dec-19 4 -0.19 -0.17 -0.24 -0.26
Year Ending Dec-19 5 -0.69 -0.64 -0.75 -0.73
Year Ending Dec-20 4 -0.32 0.07 -0.53 -0.09
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.06 34.39
P/E High - Last 5 Yrs. -- 170.35 54.26
P/E Low - Last 5 Yrs. -- 53.47 28.32
Beta -- 1.28 0.99
Price to Sales (TTM) -- 42.56 8.16
Price to Book (MRQ) -- 12.25 4.43
Price to Tangible Book (MRQ) -- 17.10 5.15
Price to Cash Flow (TTM) -- 65.05 24.27
% Owned Institutions -- 3.28 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.64
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.50 47.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 54.86 14.08
Sales (TTM) vs TTM 1 Yr. Ago -- 48.20 8.15
Sales - 5 Yr. Growth Rate -- 33.34 9.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -7.18 17.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 21.86 7.04
Capital Spending - 5 Yr. Growth Rate -- 25.24 7.83

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.83 2.54
Current Ratio (MRQ) -- 3.69 3.53
LT Debt to Equity (MRQ) -- 7.98 12.56
Total Debt to Equity (MRQ) -- 21.23 17.60
Interest Coverage (TTM) -- 31.27 14.78

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.45 50.18
Gross Margin - 5 Yr. Avg. -- 59.88 51.29
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -12.34 16.42
Operating Margin (TTM) -- -125.83 -7.11
Operating Margin - 5 Yr. Avg. -- -28.61 11.91
Pre-Tax Margin (TTM) -- -127.97 -7.48
Pre-Tax Margin - 5 Yr. Avg. -- -33.76 15.94
Net Profit Margin (TTM) -- -133.72 -11.27
Net Profit Margin - 5 Yr. Avg. -- -38.67 11.30
Effective Tax Rate (TTM) -- 17.35 20.61
Effective Tax Rate - 5 Yr. Avg. -- 19.08 24.48

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 10,290,012 881,672,098
Net Income/Employee (TTM) -- 2,290,007 103,217,315
Receivable Turnover (TTM) -- 12.47 5.91
Inventory Turnover (TTM) -- 2.43 3.66
Asset Turnover (TTM) -- 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.25 10.24
Return on Assets - 5 Yr. Avg. -- 5.94 11.20
Return on Investment (TTM) -- 7.59 12.67
Return on Investment - 5 Yr. Avg. -- 7.78 14.19
Return on Equity (TTM) -- 8.10 17.18
Return on Equity - 5 Yr. Avg. -- 8.73 15.56

Performance for Aurinia Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.